Table-III.
Evaluation of Menstruel Cycle
|
Treatment
|
P | |||
|---|---|---|---|---|
|
LNG-IUD
|
NETA
|
|||
| n (%) | n (%) | |||
| Initial Mens | HMB | 30 (%100) | 30 (%100) | 1,000 |
| 3-6. months Mens | ● HMB | 2 (%7,1) | 4 (%20) | 0,218 |
| Spotting | 18 (%64,3) | 6 (%30) | 0,0,019* | |
| ●Amenorrhea | 2 (%7,1) | 1 (%5) | 1,000 | |
| Normal Cycle | 3 (%10,7) | 7 (%35) | 0,041* | |
| ●Oligomenorrhea | 3 (%10,7) | 2 (%10) | 1,000 | |
| HMB Spotting | 1 (%3,7) 7 (%25,9) |
5 (%27,8) 4 (%22,2) |
0,031* 0,777 |
|
| Amenorrhea | 12 (%44,4) | 1 (%5,6) | 0,006** | |
| ●Normal Cycle | 2 (%7,4) | 6 (%33,3) | 0,045* | |
| ●Oligomenorrhea | 5 (%18,5) | 2 (%11,1) | 0,684 | |